ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,114,000 | +652.2% | 41,642 | +395.7% | 0.00% | +300.0% |
Q1 2021 | $414,000 | -42.9% | 8,400 | -51.3% | 0.00% | 0.0% |
Q4 2020 | $725,000 | +216.6% | 17,231 | +244.6% | 0.00% | – |
Q3 2020 | $229,000 | -53.6% | 5,000 | -37.5% | 0.00% | -100.0% |
Q4 2019 | $494,000 | +2.5% | 8,000 | +17.6% | 0.00% | 0.0% |
Q4 2018 | $482,000 | -88.2% | 6,800 | -86.6% | 0.00% | -88.9% |
Q1 2018 | $4,102,000 | +244.4% | 50,694 | +149.8% | 0.01% | +200.0% |
Q4 2017 | $1,191,000 | – | 20,290 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |